Custom peptides & Antibodies
Primary Antibodies
Secondary Antibodies
Isotype and Serum Controls
ELISA Kits
ELISA Kits and reagents for Infectious Disease and Vaccine research
ELISA Kits and reagents for Therapeutic mAbs, biosimilars, and proteins
Infectious animal disease reagents for vaccine research
ELISA, Western, LFA, IHC/ICC, and IP reagents
Peptides, Proteins, Enzymes, cDNAs, Aptamers, Adjuvants and ODNs
IHC/ICC Slides and Lysates for Westerns
TruStrip™ Rapid Tests and Sample Transfer Strips
CORONAVIRUS
New Products
ADI was founded in 1993 as a provider of custom antibodies and immunoassays for research applications. The primary focus during the early years was the development of immunoassay reagents and kits that were not readily available to researchers. As a result of the human genome project and the human proteome initiative, several new proteins were rapidly identified. However, there were no readily available reagents for carrying out detailed studies on these newly identified proteins. ADI was able to supply researchers worldwide with a number of novel reagents that enabled them to make rapid strides in proteomic research. Over the years, the company expanded its focus and product development efforts to providing solutions for unmet needs in vaccine therapeutics, biologic drugs, infectious disease testing, and other novel products directed to the consumer market which includes meat adulteration testing and rapid tests for fertility monitoring in household pets and farm animals.